title: Is the treatment of hepatocellular carcinoma on the waiting list necessary?
authors.affiliation: Department of Transplantation and Visceral Surgery, University Hospital of Geneva, Geneva, Switzerland. pietro.majno@hcuge.ch
authors.forename: Pietro
authors.initials: P
authors.lastname: Majno
authors.forename: Riccardo
authors.initials: R
authors.lastname: Lencioni
authors.forename: Françoise
authors.initials: F
authors.lastname: Mornex
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girard
authors.forename: Ronnie T
authors.initials: RT
authors.lastname: Poon
authors.forename: Daniel
authors.initials: D
authors.lastname: Cherqui
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D019317:Evidence-Based Medicine; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation; D020360:Neoadjuvant Therapy; D010352:Patient Dropouts; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018714:Radiotherapy, Adjuvant; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution*; D016896:Treatment Outcome; D014850:Waiting Lists / Q000401:mortality